Lymphoma Research Foundation

Analysis

Lymphoma Research Foundation is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in August 1996, 30 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending June 2023, Lymphoma Research Foundation reported income of $16.6m and spending of $14.0m, spending 84% of its income. Across the 5 years on record, from June 2019 to June 2023, income grew from $11.5m to $16.6m (+43%), an average of +9.4% a year. The sharpest change came in the year to June 2020, when income rose by 21%. Over the whole period it spent 72% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Lymphoma Research Foundation sits at the 87th percentile: it is larger than about 87% of them. Against every charity in United States with reported income it ranks in the 97th percentile, and in the 95th percentile within NY. Charities of a similar size with the same main cause include Heart City Health Center Inc ($16.6m), Camden on Gauley Medical Center Inc ($16.6m) and Benefis Community Care Inc ($16.5m).

On its Form 990 for the period ending June 2023, revenue came from contributions and grants 73% and program service revenue 25% of the total. Compensation of current officers, directors and key employees was $978k (7.0% of expenses). Other salaries and wages came to $2.2m. At year end it held assets of $41.1m against liabilities of $10.7m, net assets of $30.3m. It reported 38 employees.